期刊文献+

Dominant negative effect as a novel mechanism of SPAST gene mutation in a large family with hereditary spastic paraplegia

原文传递
导出
摘要 Hereditary spastic paraplegia(HSP)is a group of disorders with genetic heterogeneity,lower-extremity weakness,and spasticity are the most common signs and symptoms.SPAST is the most frequently disease-causing gene.Spastin is a microtubule-severing enzyme encoded by SPAST that cleaves long microtubules into short fragments by interacting with other proteins or membranes.Hereditary spastic paraplegia type 4(SPG4),which is autosomal dominant,is the clinical subtype associated with SPAST mutations.SPG4 accounts for up to one-third of all HSP cases and usually presents with isolated lower extremity spasticity,with or without bladder or sensory dysfunction.1 The main cause of SPG4 is believed to be spastin haploinsufficiency,which results from mutations in the SPAST gene.
出处 《Genes & Diseases》 SCIE CSCD 2024年第5期74-77,共4页 基因与疾病(英文)
基金 the Shanghai Science and Technology Innovation Action Plan Program of China(No.20Y11907200,22Y11907200) the National Natural Science Foundation of China(No.82201807) the Municipal Human Resources Development Program for Outstanding Young Talents in Medical and Health Sciences in Shanghai,China(No.2022YQ075) Shanghai“Rising Stars of Medical Talents”Youth Development Program(China).
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部